|
Canada-0-Bailiffs 公司名錄
|
公司新聞:
- Meet Our Executive Leadership Team | Sanofi
Get to know the executive leaders at Sanofi who drive innovation, commitment, and success across our global healthcare endeavors
- Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant
French drugmaker Sanofi ousted CEO Paul Hudson on Thursday, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from U S anti
- Paul Hudson (businessman) - Wikipedia
Paul Hudson (born 14 October 1967) [2] is a British businessman, and the former chief executive (CEO) of Sanofi, the world's fifth largest pharmaceutical company by prescription drug sales
- Sanofi ousts CEO Hudson, names Belén Garijo new CEO - CNBC
French drugmaker Sanofi ousted CEO Paul Hudson on Thursday appointed Belén Garijo, the head of German drugmaker Merck KGaA, as new chief executive
- Sanofi selects Dr Belén Garijo as new CEO
Sanofi has shaken up its senior leadership, jettisoning Chief Executive Officer (CEO) Paul Hudson after six years and replacing him with Merck’s Dr Belén Garijo
- Sanofi, looking for more ‘rigor,’ swaps CEO Hudson for ex-Merck KGaA . . .
Sanofi on Thursday announced the ouster of CEO Paul Hudson after a six-year tenure that included a major transformation of the French drugmaker and the rise of Dupixent into one of the world’s best-selling medicines
- Sanofi Shares Fall After CEO Change - WSJ
Sanofi SAN 0 38% shares fell after the drugmaker said Belen Garijo, the chief executive of Germany’s Merck MRK -0 14% KGaA, would succeed Paul Hudson as CEO after its board decided not to renew
- Sanofi CEO Change: Paul Hudson Exits as Belén Garijo Named Next CEO
Paul Hudson LinkedIn Following Sanofi’s announcement that Hudson’s mandate would not be renewed The company subsequently appointed Belén Garijo as his successor Garijo has served since 2021 as CEO and Chair of the Executive Board of Merck KGaA
- Sanofi ousts Paul Hudson for Merck KGaA chief after bumpy ride
Sanofi has replaced its CEO Paul Hudson after a series of R D setbacks at the French pharma, handing the reins to Merck KGaA leader Belén Garijo, M D , Ph D
- Sanofi’s stunning CEO switch—Chutes Ladders
Belén Garijo, M D , Ph D Sanofi is replacing CEO Paul Hudson with Merck KGaA leader Belén Garijo, M D , Ph D , after a series of R D setbacks at the French pharma
|
|